QuantLogix ← MS scorecard
📅 MS Earnings Preview
Morgan Stanley
Next report (est.)
October 11, 2026
Countdown
120 days
EPS growth YoY
+54.5%
Revenue growth YoY
+26.9%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
May 5, 2026 ±2.5% +0.7% over-priced
November 3, 2025 ±1.8% -0.2% over-priced
May 5, 2025 ±2.9% -0.5% over-priced
November 4, 2024 ±1.6% -0.6% over-priced
August 5, 2024 ±3.2% -3.9% under-priced
May 3, 2024 ±1.5% +1.1% over-priced
November 3, 2023 ±2.1% +3.8% under-priced
August 3, 2023 ±1.8% -0.2% over-priced
Across these reports, options implied an average ±2.2% move vs an actual average of 1.4% — the stock stayed inside the implied band 75% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $3.43 $20.6B $5.6B
Q4 FY2025 $2.68 $17.9B $4.4B
Q3 FY2025 $2.80 $18.2B $4.7B
Q1 FY2025 $2.60 $17.7B $4.4B
Analyst posture
Buy / Strong Buy
18
Hold
14
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 61/100 Full scorecard →
Get alerted before every MS report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on MS before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Morgan Stanley (MS) reports in 120 days, with the next report estimated for October 11, 2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced MS's earnings risk. Fundamentals into the print: EPS up 54.5% year-over-year, revenue up 26.9%. QuantLogix's live 5-factor engine currently reads MS as a buy at 61/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →